CO-67 | CONGENITAL DYSFIBRINOGENEMIA: BLEEDING PHENOTYPE, THROMBOTIC COMPLICATIONS, AND LONG-TERM MANAGEMENT IN A MULTICENTER COHORT
Background and Aims. Congenital dysfibrinogenemia is a disorder caused by structural abnormalities of the fibrinogen molecule, resulting in impaired fibrinogen function. While most patients remain asymptomatic, some may present with bleeding manifestations and/or an increased risk of thrombosis. This multicenter study...